I agree that this site is using cookies. You can find further informations here.
X
Álvarez-Larrán, Alberto
88  results:
OpenAccess-fulltext X
Search for persons X
?
1

Integrating AIPSS-MF and molecular predictors: A comparativ..:

Mosquera-Orgueira, Adrián ; Arellano-Rodrigo, Eduardo ; Garrote, Marta...
https://www.repository.cam.ac.uk/handle/1810/368083.  , 2024
Link: https://www.repository.c..
 
?
2

CNL and aCML should be considered as a single entity based ..:

Carreño-Tarragona, Gonzalo ; Álvarez-Larrán, Alberto ; Harrison, Claire...
https://doi.org/10.1182/bloodadvances.2022008204..  , 2023
Link: https://hdl.handle.net/2..
 
?
3

Risk of progression in chronic phase-chronic myeloid leukem..:

Zambrotta, Giovanni Paolo Maria ; Nicolini, Franck E ; Assouline, Sarit...
info:eu-repo/semantics/altIdentifier/pmid/37647134.  , 2023
Link: https://hdl.handle.net/1..
 
?
4

Application of IPSET-thrombosis in 1366 Patients Prospectiv..:

Alvarez-Larran, Alberto ; Cuevas, Beatriz ; Velez Tenza, Patricia...
HemaSphere;7(8).  , 2023
Link: https://hdl.handle.net/1..
 
?
5

Real-world analysis of main clinical outcomes in patients w..:

Alvarez-Larrán, Alberto ; Garrote, Marta ; Ferrer-Marín, Francisca...
http://hdl.handle.net/10668/21618.  , 2022
Link: http://hdl.handle.net/10..
 
?
6

Correction to: Low‑risk polycythemia vera treated with phle..:

Triguero, Ana ; Pedraza, Alexandra ; Perez-Encinas, Manuel...
http://hdl.handle.net/10668/19731.  , 2022
Link: http://hdl.handle.net/10..
 
?
7

Breakthrough infections in MPN-COVID vaccinated patients:

Barbui, Tiziano ; Carobbio, Alessandra ; Cuevas, Beatriz...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41408-022-00749-8.  , 2022
Link: https://publications.rwt..
 
?
8

Impact of Individual Comorbidities on Survival of Patients ..:

García-Fortes, María ; Hernández-Boluda, Juan C ; Álvarez-Larrán, Alberto...
2072-6694.  , 2022
Link: http://hdl.handle.net/10..
 
?
9

Machine Learning Improves Risk Stratification in Myelofibro..:

Mosquera-Orgueira, Adrián ; Pérez-Encinas, Manuel ; Hernández-Sánchez, Alberto...
HemaSphere.  , 2022
Link: https://ddd.uab.cat/reco..
 
?
10

Breakthrough infections in MPN-COVID vaccinated patients:

Barbui, Tiziano ; Carobbio, Alessandra ; Ghirardi, Arianna...
Blood Cancer Journal.  , 2022
Link: https://ddd.uab.cat/reco..
 
?
11

Phase III MANIFEST-2:pelabresib + ruxolitinib vs placebo + ..:

Harrison, Claire N ; Gupta, Vikas K ; Gerds, Aaron T...
https://research.vumc.nl/en/publications/ef2e9788-42e0-4426-a409-614e04018428.  , 2022
Link: https://research.vumc.nl..
 
?
12

Phase III MANIFEST-2:pelabresib + ruxolitinib vs placebo + ..:

Harrison, Claire N ; Gupta, Vikas K ; Gerds, Aaron T...
https://research.vumc.nl/en/publications/ef2e9788-42e0-4426-a409-614e04018428.  , 2022
Link: https://research.vumc.nl..
 
?
13

Impact of ruxolitinib on survival of patients with myelofib..:

Guglielmelli, Paola ; Ghirardi, Arianna ; Carobbio, Alessandra...
info:eu-repo/semantics/altIdentifier/pmid/34753179.  , 2022
Link: https://hdl.handle.net/1..
 
?
14

Philadelphia-negative chronic myeloproliferative neoplasm f..:

Ortuzar, Ariana ; Fox, María Laura ; Vera, Juan Antonio...
http://hdl.handle.net/10668/19742.  , 2022
Link: http://hdl.handle.net/10..
 
?
15

Breakthrough infections in MPN-COVID vaccinated patients:

Barbui, Tiziano ; Carobbio, Alessandra ; Ghirardi, Arianna...
info:eu-repo/semantics/altIdentifier/pmid/36379921.  , 2022
Link: https://hdl.handle.net/1..
 
1-15